Subscribe for stories that matter!
Whitefort Capital Management is urging Warminster-based Arbutus Biopharma to look at all options for its lead product portfolio instead of just diluting investor holdings…
Warminster biotech company Arbutus Biopharma shared promising results from its latest study on a new treatment for hepatitis B, writes John George for the Philadelphia…
Mike Sofia, a renowned scientist, is set to retire as Chief Scientific Officer at Warminster-based Arbutus Biopharma by the end of the year, writes…
William Collier, president and CEO of Warminster-based Arbutus Biopharma, will retire from his positions effective December 31, writes John George for the Philadelphia Business…
A biopharmaceutical company in the Bucks County area is taking legal action against two major groups over their widely-lauded vaccines. John George wrote about…
Arbutus Biopharma Corp., Warminster, has filed a patent infringement lawsuit against Moderna Inc. The claim seeks unspecified damages related to Moderna’s widely distributed COVID…
Arbutus Biopharma, Warminster, has entered a $300 million licensing and partnership deal with a Chinese biopharmaceutical firm. enters into $300M deal for experimental hepatitis B…
Before we send you to this site, please subscribe to our daily newsletter.
